INCY

Incyte (INCY)

About Incyte (INCY)

Incyte Corp. is a biopharmaceutical company, which engages in the discovery, development, and commercialization of proprietary therapeutics. It focuses on hematology and oncology, and inflammation and autoimmunity therapeutic areas. The company was founded on April 8, 1991 and is headquartered in Wilmington, DE.

Details

Daily high

$91.70

Daily low

$89.25

Price at open

52 Week High

$112.29

52 Week Low

$53.56

Market cap

18.0B

Dividend yield

0.00%

Volume

112

Avg. volume

1.8M

P/E ratio

14.15

Incyte News